Chapter title |
Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: An Update.
|
---|---|
Chapter number | 7 |
Book title |
Lung Cancer and Personalized Medicine
|
Published in |
Advances in experimental medicine and biology, December 2015
|
DOI | 10.1007/978-3-319-24223-1_7 |
Pubmed ID | |
Book ISBNs |
978-3-31-924221-7, 978-3-31-924223-1
|
Authors |
Ahsan, Aarif, Aarif Ahsan |
Editors |
Aamir Ahmad, Shirish Gadgeel |
Abstract |
Resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in non small cell lung cancer (NSCLC) is mediated by two major mechanisms namely secondary mutation T790M in EGFR and cMET amplification. Other molecular mediators which contribute towards TKI resistance include the activation of compensatory growth signaling, epithelial mesenchymal transition and microRNAs regulating EGFR and cMET levels. In this chapter, we have included the major mechanisms which contribute towards EGFR TKI resistance in NSCLC. Several therapeutic approaches to overcome TKI resistance are also presented which include second and third generation EGFR TKI inhibitors and cMET inhibitors. Further, the rationale to utilize the combination therapies to simultaneously target EGFR and other major oncogene addictive pathway such as ERBB2 and AXL kinase is outlined. Another promising approach to overcome TKI resistance is to potentiate EGFR protein for degradation. These studies will best be utilized when we can identify the oncogene addictions in an individual patient and tailor the therapy/therapies accordingly for the maximum benefits. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 46 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 22% |
Student > Master | 6 | 13% |
Researcher | 6 | 13% |
Student > Doctoral Student | 3 | 7% |
Student > Bachelor | 3 | 7% |
Other | 5 | 11% |
Unknown | 13 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 12 | 26% |
Agricultural and Biological Sciences | 9 | 20% |
Medicine and Dentistry | 7 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 9% |
Neuroscience | 1 | 2% |
Other | 0 | 0% |
Unknown | 13 | 28% |